Stock 0575 REGENT PACIFIC GROUP LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Regent Pacific Group Ltd. Hong Kong S.E.

Equities

0575

KYG7478U1388

Pharmaceuticals

Business Summary

Regent Pacific Group Ltd, formerly Endurance RP Ltd is an investment holding company principally engaged in biopharma and investment businesses. The Company operates its business through two segments. The Biopharma segment is engaged in the research, development, manufacture, marketing and sale of pharmaceutical products. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The Company is also engaged in aging research and developing artificial intelligence (AI) models and tool products related to aging research. It offers aging and longevity clocks to the longevity clinics, preventative medicine organizations, health clubs, insurance companies, and aging research institutions.

Sales per Business

HKD in Million2022Weight2023Weight Delta
Biopharma
100.0 %
0 100.0 % 2 100.0 % +731.26%

Sales per region

HKD in Million2022Weight2023Weight Delta
Europe
83.5 %
0 31.4 % 2 83.5 % +2,108.65%
United States
12.0 %
-- 0 12.0 % -
Asia Pacific
4.5 %
-- 0 4.5 % -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 228,392,286 91,878,722 ( 40.23 %) 0 40.23 %

Shareholders

NameEquities%Valuation
Canaccord Genuity Asset Management Ltd.
0.0340 %
77,657 0.0340 % 3 971 $
Quilvest Switzerland Ltd.
0.006568 %
15,000 0.006568 % 767 $

Holdings

NameEquities%Valuation
CONDOR GOLD PLC
0.25%
 499,000 0.25% 206,192 $
TRINITY EXPLORATION & PRODUCTION PLC
0.11%
 41,000 0.11% 18,482 $

Company contact information

Regent Pacific Group Ltd.

8th Floor, Henley Building 5 Queen's Road Central

, Hong Kong

+852 2514 6111

http://www.endurancerp.com
address Regent Pacific Group Ltd.(0575)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+39.82% 734B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.75% 591B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.31% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+14.23% 315B
ABBVIE INC. Stock AbbVie Inc.
+0.86% 276B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.11% 238B
ROCHE HOLDING AG Stock Roche Holding AG
-6.34% 204B
NOVARTIS AG Stock Novartis AG
+8.60% 206B
AMGEN INC. Stock Amgen Inc.
+4.51% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 575 Stock
  4. 0575 Stock
  5. Company Regent Pacific Group Ltd.